Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pfister

Showing results (111-120 of 194) with videos related to

Pageof 20
Sort By:
Cancer Chemotherapy and Pharmacology|September 14, 2011
A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumorsMatthew G Fury, Eric Sherman, Sofia Haque, et al.
The Prostate|December 24, 2022
Importance of magnetic resonance imaging and prostate-specific membrane antigen PET-CT in patients treated with salvage radical prostatectomy for radiorecurrent prostate cancerPawel Rajwa, David Pfister, Constantin Rieger, et al.
PLOS Digital Health|June 7, 2023
Validation and implementation of a mobile app decision support system for prostate cancer to improve quality of tumor boardsYasemin Ural, Thomas Elter, Yasemin Yilmaz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 17, 2023
Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancerJohannes Rosenbrock, Christian Baues, Marius Kreis, et al.
World Journal of Urology|December 15, 2018
Predictors of thrombosis in testicular cancer during platinum-based chemotherapyPia Paffenholz, Katharina Grein, Isabel Heidegger, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 5, 2017
Testicular Cancer on the Web-an Appropriate Source of Patient Information in Concordance with the European Association of Urology Guidelines?Pia Paffenholz, Johannes Salem, Hendrik Borgmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2016
Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CTDavid Pfister, Daniel Porres, Axel Heidenreich, et al.
BMJ Quality & Safety|June 29, 2017
Peers without fears? Barriers to effective communication among primary care physicians and oncologists about diagnostic delays in cancerAllison Lipitz-Snyderman, Minal Kale, Laura Robbins, et al.
European Radiology|December 13, 2019
Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissectionBettina Baessler, Tim Nestler, Daniel Pinto Dos Santos, et al.
Radiation Oncology (London, England)|December 12, 2012
Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapyMichael Pinkawa, Marc D Piroth, Richard Holy, et al.
Pageof 20

Showing results (111-120 of 194) with videos related to

Sort By:
Pageof 20
Cancer Chemotherapy and Pharmacology|September 14, 2011
A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumorsMatthew G Fury, Eric Sherman, Sofia Haque, et al.
The Prostate|December 24, 2022
Importance of magnetic resonance imaging and prostate-specific membrane antigen PET-CT in patients treated with salvage radical prostatectomy for radiorecurrent prostate cancerPawel Rajwa, David Pfister, Constantin Rieger, et al.
PLOS Digital Health|June 7, 2023
Validation and implementation of a mobile app decision support system for prostate cancer to improve quality of tumor boardsYasemin Ural, Thomas Elter, Yasemin Yilmaz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 17, 2023
Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancerJohannes Rosenbrock, Christian Baues, Marius Kreis, et al.
World Journal of Urology|December 15, 2018
Predictors of thrombosis in testicular cancer during platinum-based chemotherapyPia Paffenholz, Katharina Grein, Isabel Heidegger, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 5, 2017
Testicular Cancer on the Web-an Appropriate Source of Patient Information in Concordance with the European Association of Urology Guidelines?Pia Paffenholz, Johannes Salem, Hendrik Borgmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2016
Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CTDavid Pfister, Daniel Porres, Axel Heidenreich, et al.
BMJ Quality & Safety|June 29, 2017
Peers without fears? Barriers to effective communication among primary care physicians and oncologists about diagnostic delays in cancerAllison Lipitz-Snyderman, Minal Kale, Laura Robbins, et al.
European Radiology|December 13, 2019
Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissectionBettina Baessler, Tim Nestler, Daniel Pinto Dos Santos, et al.
Radiation Oncology (London, England)|December 12, 2012
Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapyMichael Pinkawa, Marc D Piroth, Richard Holy, et al.
Pageof 20